topic

1509 Characterizing somatostatin receptor 2 (SSTR2) expression and the immune landscape of olfactory neuroblastoma (ONB), sinonasal neuroendocrine carcinoma (SNEC), and sinonasal undifferentiated carcinoma (SNUC)
Dara Bracken-Clarke, Harris Krause, Nishant Gandhi, Alex Farrell, Heloisa Soares, Minh Phan, Rusha Patel, Ari VanderWalde, Nyall London, James L Gulley, Emil Lou, Charalampos S Floudas

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A1674; DOI: 10.1136/jitc-2023-SITC2023.1509
Author index
Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A1675-A1726; DOI: 10.1136/jitc-2023-SITC2023.authorindex
1316 Enabling single-cell resolution in spatial transcriptomics for comprehensive cellular profiling with variational autoencoders and optimal transport
Long Yuan, Xuyang Li, Janis Taube, Alexander Szalay

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A1466-A1467; DOI: 10.1136/jitc-2023-SITC2023.1316
1317 Enhancing patient safety in melanoma treatment: harnessing machine learning for predicting immune-related adverse events
Yili Zhang, Shaked Lev Ari, Samir Gupta, Jacob Zaemes, Neil J Shah, Adil Alaoui, Subha Madhavan, Peter McGarvey, Michael B Atkins

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A1468; DOI: 10.1136/jitc-2023-SITC2023.1317
1318 Characterization of T cell specificity and exercise-induced dynamics of soluble immunological markers before and after high-intensity aerobic exercise (inhale)
Katharina Leuchte, Sara Fresnillo Saló, Thy V Luu, Anders Vinther, Gitte Olofsson, Per Thor Straten

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A1469; DOI: 10.1136/jitc-2023-SITC2023.1318
1319 Exploring mechanisms by which physical exercise fuels antitumor CD8+ T cell immunity against immunotherapy resistant melanoma
Catherine M Phelps, Jake Shapira, Alex C McPherson, Colin Laughlin, Marlies Meisel

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A1470; DOI: 10.1136/jitc-2023-SITC2023.1319
1320 Helicobacter hepaticus colonization endows immunotherapeutic sensitivity in refractory melanoma tumors
Jessica Jana, Kristin Morder, Katelyn Wolfgang, Abigail E Overacre-Delgoffe

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A1471; DOI: 10.1136/jitc-2023-SITC2023.1320
1321 Evaluation of a new co-cultured microbiome ecosystem therapy candidate (MaaT03X) for clinical testing as adjuvant/neoadjuvant to immune checkpoint inhibitors in solid tumors
Bastien Laperrousaz, Julie Reygner, Emmanuel Prestat, Cyrielle Gasc, Charlotte Petitjean, Aurore Duquenoy, Lora Martin, Vincent Bonnaud, Marianne Robin, Sophie Declomesnil, Carole Schwintner, Nathalie Corvaia

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A1472; DOI: 10.1136/jitc-2023-SITC2023.1321
1322 Too sweet to be true: sucralose ablates immunotherapy response through microbiome disruption
Kristin Morder, Drew Wilfahrt, Bingxian Xie, Diwakar Davar, Hector Nieves-Rosado, Douglas Prado, Madison Nguyen, William Hawse, Larry Kane, Stacy Wendell, Jishnu Das, Greg Delgoffe, Abigail E Overacre-Delgoffe

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A1473; DOI: 10.1136/jitc-2023-SITC2023.1322
1323 Changes in the microbiome after treatment: are we setting colorectal cancer patients back before they begin?
Kristin Morder, Jessica Jana, Katelyn Wolfgang, Abigail E Overacre-Delgoffe

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A1474; DOI: 10.1136/jitc-2023-SITC2023.1323

Main menu

topic

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

topic

Pages